Skip to main content
logo
Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
199.05
+2.55 (1.30%)
At close: Jul 28, 2026, 4:00 PM EDT
196.85
-2.20 (-1.11%)
After-hours: Jul 28, 2026, 7:15 PM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21 Dec '20 Oct '20
Biotechnology Revenue
1.92B
Life Sciences Revenue
1.88B
Former Life Sciences Revenue
3.80B
Diagnostics Revenue
2.47B
Revenue (Other)
-3.80B
Revenue (Total)
6.27B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21 Dec '20 Oct '20
North America Revenue
2.47B
Western Europe Revenue
1.54B
Other Developed Markets Revenue
293.00M
High-Growth Markets Revenue
1.96B
Revenue (Total)
6.27B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21 Dec '20 Oct '20
Recurring Revenue
5.20B
Non-Recurring Revenue
1.07B
Revenue (Total)
6.27B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21 Dec '20 Oct '20
Biotechnology Operating Income
556.00M
Life Sciences Operating Income
244.00M
Former Life Sciences Operating Income
800.00M
Diagnostics Operating Income
416.00M
Operating Income (Other)
-89.00M
Operating Income (Total)
1.13B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21 Apr '21 Dec '20 Oct '20
Core Sales Growth
3.00%